Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Barile-Fabris

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Rheumatology Reports|July 16, 2014
Vasculitis in systemic lupus erythematosusL Barile-Fabris, M F Hernández-Cabrera, J A Barragan-Garfias
Clinical and Experimental Dermatology|January 25, 2005
Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1beta, TNF-alpha, TGF-beta1, ELAM-1 and VCAM-1 expression in scleroderma skin lesionsJ Furuzawa-Carballeda, E Krötzsch, L Barile-Fabris, et al.
Lupus|March 13, 2003
Neurological involvement as a poor prognostic factor in catastrophic antiphospholipid syndrome: autopsy findings in 12 casesL Olguín-Ortega, L J Jara, M Becerra, et al.
Annals of the Rheumatic Diseases|March 17, 2005
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosusL Barile-Fabris, R Ariza-Andraca, L Olguín-Ortega, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness studyP Emery, J E Gottenberg, A Rubbert-Roth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Rheumatology Reports|July 16, 2014
Vasculitis in systemic lupus erythematosusL Barile-Fabris, M F Hernández-Cabrera, J A Barragan-Garfias
Clinical and Experimental Dermatology|January 25, 2005
Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1beta, TNF-alpha, TGF-beta1, ELAM-1 and VCAM-1 expression in scleroderma skin lesionsJ Furuzawa-Carballeda, E Krötzsch, L Barile-Fabris, et al.
Lupus|March 13, 2003
Neurological involvement as a poor prognostic factor in catastrophic antiphospholipid syndrome: autopsy findings in 12 casesL Olguín-Ortega, L J Jara, M Becerra, et al.
Annals of the Rheumatic Diseases|March 17, 2005
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosusL Barile-Fabris, R Ariza-Andraca, L Olguín-Ortega, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness studyP Emery, J E Gottenberg, A Rubbert-Roth, et al.
Pageof 1